Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P214. Mesenchymal stromal cells increase the effectiveness of anti-inflammatory therapy and help to increase the duration of remission in newly diagnosed Crohn's disease
P214. Mucosal healing an essential efficacy measure in ulcerative colitis: Effect of country-enrollment site in a phase IIa study with interferon-β-1a
P214

Ulcerative Proctitis: Predictors and outcomes of disease extension in UC

Authors:

K. Boland*1, O. Kelly1, D. Keegan1, K. Sheahan2, H. Mulcahy1, G. Cullen1, G.A. Doherty1

1St Vincent's University Hospital, Department of Gastroenterology, Dublin 4, Ireland, 2St Vincent's University Hospital, Department of Pathology, Dublin 4, Ireland

P215.

Growth pattern and growth failure in paediatric Crohn's disease are related to inflammatory status but not to duration of steroid therapy

Authors:

D. Ley1, H. Béhal2, C. Gower-Rousseau3,4, A. Duhamel2, M. Fumery5, F. Vasseur4, L. Michaud1, I. Rousseau4, G. Savoye6, D. Turck1, 1University and Hospital, Paediatric, Lille, France, 2University and Hospital, Biostatistics EA 2694, Lille, France, 3Health, Epidemiology, Lille, France, 4University and Hospital, Epidemiology, Lille, France, 5University and Hospital, Gastroenterology, Amiens, France, 6University and Hospital, Gastroenterology, Rouen, France

P215. Biologic therapy versus conventional therapies in a series of Crohn's disease patients: A pair-matched study
P215. Endoscopic remission (Mayo score 0 rather than score 1) predicts long-term clinical remission in ulcerative colitis
Authors:

N. Inoue1, K. Takabayashi2, T. Takayama2, K. Matsuoka2, M. Naganuma3, T. Hisamatsu2, Y. Hayashi4, T. Kanai2, H. Ogata3, Y. Iwao1, T. Hibi2, 1Keio University School of Medicine, Center for Preventive Medicine, Tokyo, Japan, 2Keio University School of Medicine, Division of Gastroenterology & Hepatology, Department of Internal Medicine, Tokyo, Japan, 3Keio University School of Medicine, Center for Diagnostic and Therapeutic Endoscopy, Tokyo, Japan, 4Keio University School of Medicine, Department of Pathology, Tokyo, Japan

P215. Iron deficiency in Crohn's: Serum ferritin, disease location, and inflammatory markers
P215

Correlation of histological activity and basal plasmacytosis with mucosal healing in ulcerative colitis patients

Authors:

K. Farkas*1, Z. Reisz2, A. Sejben2, L. Tiszlavicz2, M. Szücs3, Z. Szepes1, F. Nagy1, M. Rutka1, A. Bálint1, R. Bor1, Á. Milassin1, T. Molnár1

1University of Szeged, 1st Department of Medicine, Szeged, Hungary, 2University of Szeged, Department of Pathology, Szeged, Hungary, 3University of Szeged, Department of Medical Physics and Informatics, Szeged, Hungary

P216.

Fecal calprotectin and lactoferrin as predictors of relapse in patients with quiescent ulcerative colitis during maintenance therapy

Authors:

T. Yamamoto, M. Shiraki, S. Umegae, K. Matsumoto, Yokkaichi Social Insurance Hospital, Inflammatory Bowel Disease Centre, Yokkaichi, Japan

P216. Effectiveness of a dose “de-escalation” strategy with anti-TNF drugs in patients with Crohn's disease (CD)
P216. Factors associated with use of azathioprine in patients with ulcerative colitis
P216. Inflammatory bowel disease unclassified (IBDU) in real practice: prevalence, clinical course and therapy requirements
Authors:

F. Bermejo1, A. Algaba1, J.L. Cuño2, B. Botella3, C. Taxonera4, M. Calvo5, P. López-Serrano6, L. Ballesteros7, M. Chaparro8, A. Ponferrada9, N. Manceñido10, G. de-la-Poza1, A. López-San Román2, D. Martin3, D. Olivares4, Y. González-Lama5, J.L. Pérez-Calle6, G. Gómez7, J.P. Gisbert8, I. Guerra1, 1Hospital Universitario de Fuenlabrada, Gastroenterology, Fuenlabrada, Spain, 2Hospital Universitario Ramón y Cajal, Gastroenterology, Madrid, Spain, 3Hospital Infanta Cristina, Gastroenterology, Parla, Spain, 4Hospital Clínico Universitario San Carlos, Gastroenterology, Madrid, Spain, 5Hospital Universitario Puerta de Hierro, Gastroenterology, Madrid, Spain, 6Hospital Universitario Fundación Alcorcón, Gastroenterology, Alcorcón, Spain, 7Hospital Universitario 12 de Octubre, Gastroenterology, Madrid, Spain, 8Hospital Universitario de La Princesa, and Instituto de Investigación Sanitaria Princesa (IP), Madrid. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Gastroenterology, Madrid, Spain, 9Hospital Universitario Infanta Leonor, Gastroenterology, Madrid, Spain, 10Hospital Universitario Infanta Sofía, Gastroenterology, Madrid, Spain

P216

Defensins alpha 5 and 6 are up-regulated in the colonic mucosa from patients with Ulcerative Colitis and are associated with clinical outcomes

Authors:

J. Yamamoto-Furusho*, P. Vidal-Cevallos, G. Fonseca-Camarillo

IBD Clinic, Instituto Nacional de Ciencias Medicas y Nutricion, Gastroenterology, Mexico, Mexico

P217.

Family functioning and health-related quality of life in children with inflammatory bowel disease

Authors:

L. Caes1, C.T. Chambers1,2,3, A. Otley2, 1IWK Health Centre, Centre for Pediatric Pain Research, Halifax, Canada, 2Dalhousie University, Department of Pediatrics, Halifax, Canada, 3Dalhousie University, Department of Psychology and Neuroscience, Halifax, Canada

P217. Inflammatory bowel disease is associated with higher mortality and length of hospitalisation in patients undergoing hematopoietic stem cell transplantation: a nationwide study
Authors:

M. Dave1, K. Mehta2, 1Mayo Clinic, Gastroenterology and Hepatology, Rochester, United States, 2Drexel University School of Public Health, Department of Epidemiology and Biostatistics, Philadelphia, United States

P217. Local injection of infliximab in severe fistulating perianal Crohn's disease: Long-term follow-up
P217. The efficacy of anti-TNF‑α antibody infliximab in refractory ulcerative colitis: Its positioning among the variety of treatment options
P217

The use of imaging techniques in the diagnosis and management of Crohn's Disease: Results of a national survey (Raymond study) aimed at Spanish gastroenterologists and radiologists

Authors:

A. Gutiérrez*1, I. Ordás2, I. Marín-Jiménez3, J. Hinojosa4, J. Rimola5, A. Torregrosa6

1Hospital General Universitary Alicante, Gastroenterology, Alicante, Spain, 2Hospital Clinic of Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Gastroenterology, Barcelona, Spain, 3Hospital General Universitario "Gregorio Marañón", Gastroenterology Unit, Madrid, Spain, 4Hospital de Manises, IBD unit, Manises, Spain, 5Hospital Clinic of Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Radiology, Barcelona, Spain, 6Hospital La Fe, Radiology Department, Valencia, Spain

P218.

Faecal calprotectin testing reduces need for paediatric colonoscopy

Authors:

T.I. Hassan1, C. Hensey1, M. Hamzawi1, S. Kiernana1, A.-M. Broderick1,2, B. Bourke1,2, S. Hussey1,2, 1Our Lady's Children's Hospital Crumlin, Gastroenterology, Dublin, Ireland, 2University college Dublin, National children reseach centre and school of Medicine and Medical Science, Dublin, Ireland

P218. Effect of infliximab on the level of adhesion molecules in inflammatory bowel disease